Physician profile
Michael Mcalister
NPI 1629398276
$860.56
in general payments reported to CMS, 2019-2025
14 companies · $82.68 in 2025
The $82.68 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.88 · 2020: $122 · 2021: $146 · 2022: $157 · 2023: $230 · 2024: $55.24 · 2025: $82.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $375.27 | 2020-2025 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $139.02 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $59.05 | 2021-2023 | Shingrix, Bexsero, Boostrix |
| Astrazeneca Pharmaceuticals LP | $58.65 | 2019-2023 | Farxiga |
| Abbvie INC. | $47.22 | 2021-2023 | |
| Pfizer INC. | $42.41 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.16 | 2024-2025 | Jardiance |
| Eisai INC. | $25.50 | 2024 | |
| Acadia Pharmaceuticals INC | $17.24 | 2025 | Nuplazid |
| Exact Sciences Corporation | $16.01 | 2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $15.42 | 2019 | |
| Amgen INC. | $15.16 | 2022 | |
| Boston Scientific Corporation | $11.21 | 2021 | |
| Corium, LLC | $10.24 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcalister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.